Table 1 Basic characteristics of the study groups
Characteristic | Alfentanil group (n=129) | Fentanyl group (n=131) | P value |
|---|---|---|---|
Age, mean±SD (range), y | 53.54±10.30 (27–85) | 52.34±11.55 (29–87) | 0.378 |
Male/Female | 66/63 | 67/64 | 1.000 |
Body weight, mean (SD), kg | 62.57 (11.03) | 61.55 (11.69) | 0.362 |
BMI, mean (SD), kg/m2 | 23.86 (3.42) | 24.00 (3.75) | 0.507 |
ASA classification, n (%) | Â | Â | 1.000 |
I | 39 (30.2) | 40 (30.5) | Â |
II | 82 (63.6) | 82 (62.6) | Â |
III | 8 (6.2) | 9 (6.9) | Â |
IV | 0 | 0 | Â |
Baseline SBP, mean (SD), mm Hg | 118.26 (14.27) | 121.79 (16.84) | 0.070 |
Baseline DBP, mean (SD), mm Hg | 76.11 (10.92) | 76.95 (12.83) | 0.568 |
Baseline MAP, mean (SD), mm Hg | 89.26 (11.22) | 90.98 (13.25) | 0.260 |
Baseline HR, mean (SD), beats/min | 71.36 (11.34) | 72.65 (11.84) | 0.372 |
Baseline SpO2, mean (SD), % | 97.76 (1.02) | 97.74 (0.99) | 0.874 |